Avascular Necrosis Market Opportunities Are Emerging Beyond Traditional Growth Areas
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Avascular Necrosis Market Growth Analysis: How Will Revenue Expand During The Forecast Period?
The market for avascular necrosis has experienced notable expansion in recent years. Projections indicate an increase from $0.89 billion in 2025 to $0.97 billion in 2026, reflecting a compound annual growth rate (CAGR) of 9.5%. Factors driving growth during the historical period include trauma-induced bone injuries, excessive steroid usage, alcohol intake, delays in diagnosis, and the expansion of orthopedic surgical procedures.
The avascular necrosis market is projected to experience robust expansion over the coming years, reaching a valuation of $1.38 billion by 2030, corresponding to a compound annual growth rate (CAGR) of 9.2%. This anticipated growth during the forecast period is driven by several factors, including the adoption of advanced imaging techniques, ongoing research into regenerative medicine, an aging global population, a high incidence of sports-related injuries, and advancements in orthopedics. Key developments shaping this market encompass the growing utilization of early diagnostic imaging tools, an increasing emphasis on therapies designed to preserve joints, the rise of minimally invasive surgical options, the expansion of physical rehabilitation initiatives, and a heightened focus on managing the condition during its early stages.
Download A Free Sample Report For Comprehensive Market Insights:
Avascular Necrosis Market Growth Momentum: Which Factors Are Influencing Demand?
The anticipated rise in the market for avascular necrosis is being significantly driven by the increasing frequency of knee replacement and hip surgeries. These surgical interventions, designed to replace damaged joints and alleviate pain in advanced cases of avascular necrosis, are becoming more common primarily due to the rising prevalence of osteoarthritis—a condition that leads to severe joint discomfort and impaired mobility, often necessitating surgery for relief and enhanced quality of life. Avascular necrosis itself plays a critical role in driving the demand for these procedures, as it causes bone tissue death from inadequate blood supply, frequently resulting in joint deterioration and collapse. As an example, data from November 2024 released by the American Joint Replacement Registry (AJRR), a registry managed by the American Academy of Orthopaedic Surgeons in the United States, revealed that the number of hip and knee arthroplasty procedures recorded in the registry exceeded 4 million in 2023, reflecting an 18% growth compared to 2022. Consequently, the expansion of the avascular necrosis market is being fueled by this surge in knee replacements and hip surgeries.
Driver: Higher Healthcare Spending Boosts the Avascular Necrosis Market through Better Diagnostics and Treatment Accessibility
The avascular necrosis market is expected to be propelled forward by the increasing level of healthcare spending. This expenditure encompasses the total funds allocated to health services, treatments, and medical products within a given population or healthcare system. The growth in healthcare spending is driven by a higher incidence of chronic diseases, which demand ongoing management, frequent hospital visits, and expensive medications. Such expenditure proves valuable for avascular necrosis by facilitating access to timely diagnoses, advanced therapeutic options, and surgical interventions that help control the condition and enhance patient outcomes. For example, the American Medical Association—a U.S.-based professional organization and advocacy group representing physicians and medical students—reported in April 2025 that health spending in the United States rose by 7.5% in 2023, reaching $4.9 trillion, or $14,570 per person, surpassing the 4.6% increase observed in 2022. Therefore, the upward trend in healthcare expenditure is accelerating the growth of the avascular necrosis market.
Avascular Necrosis Market Categorization By Product Type And Application
The avascular necrosis market covered in this report is segmented –
1) By Type: Trauma Related Avascular Necrosis, Non-Trauma Related Avascular Necrosis
2) By Diagnosis: Imaging, Biopsy, Computed Tomography Scan, Positron Emission Tomography, X-Ray
3) By Treatment Type: Medications, Surgery, Physical Therapy, Lifestyle Changes, Bone Grafting
4) By End-User: Hospitals, Specialty Clinics, Rehabilitation Centers, Ambulatory Surgical Centers, Home Care Settings
Subsegments:
1) By Trauma-Related Avascular Necrosis: Fracture-Induced Avascular Necrosis, Dislocation-Induced Avascular Necrosis, Post-Surgical Avascular Necrosis, Crush Injury-Related Avascular Necrosis, Sports Injury-Associated Avascular Necrosis
2) By Non-Trauma Related Avascular Necrosis: Steroid-Induced Avascular Necrosis, Alcohol-Induced Avascular Necrosis, Sickle Cell Disease-Associated Avascular Necrosis, Lupus-Related Avascular Necrosis, Radiation Therapy-Induced Avascular Necrosis, Idiopathic Avascular Necrosis
Avascular Necrosis Market Company Landscape And Strategic Competition
Major companies operating in the avascular necrosis market are Stryker Corporation, Massachusetts General Hospital, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Stanford Health Care, Apollo Hospitals Enterprise Limited, Singapore General Hospital Pte Ltd., Fortis Healthcare Limited, Narayana Hrudayalaya Limited, Bumrungrad International Hospital Co. Ltd., Aster DM Healthcare Limited, Mount Elizabeth Hospital Pte Ltd., Gleneagles Hospital Pte Ltd., Shalby Limited, Texas Orthopedic Hospital LLC, Regrow Biosciences Pvt. Ltd., Maxcure Hospitals Limited, Medicover Hospitals Private Limited, Mesoblast Limited, Athersys Inc.
Access The Complete Avascular Necrosis Market Report:
Avascular Necrosis Market Global Footprint: Which Region Holds Market Leadership?
North America was the largest region in the avascular necrosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the avascular necrosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
